The ability of either cocaine or amphetamine to enhance monoaminergic neurotransmission via inhibition of neuronal uptake is thought to be one mechanism that contributes to their psychotropic properties. The proposed experimental plan seeks to understand potential changes in synaptic neurobiology as a consequence of increased transmitter levels. Specifically, studies are proposed to 1) define the interaction of serotonin (5HT) and dopamine (DA) in areas of the brain relevant to drug self-administration such as the medial prefrontal cortex and nucleus accumbens, 2) determine the consequence of repeated cocaine or amphetamine on presynaptic autoreceptor function, postsynaptic DA sensitive adenylate cyclase, and the relative balance of D1/D2 influence at each site, 3) define further the mechanisms by which amphetamine and cocaine alter DA or 5HT synthesis in intact nerve terminals. Objectives will be realized with a combination of neurochemical techniques, including DA and 5HT synthesis in vivo, synthesis and release in striatal brain slices in vitro, brain microdialysis to measure transmitter release in vivo, and adenylate cyclase determinations. Advances in understanding the neurobiology of cocaine and amphetamine have not kept pace with the exponential increase in drug abuse. Nonetheless, successful, pharmacological-based withdrawal programs for drug abstinence require knowledge of the molecular mechanisms associated with drug self- administration and craving. By examining the effects of both acute and chronic exposure to these drugs of abuse, the proposed experiments will yield insight into both the mechanism of action and the functional consequences of stimulant abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
2R01DA004120-04A1
Application #
3209268
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1986-07-01
Project End
1993-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
4
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
Schools of Medicine
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Chapman, Mary Ann; Roll, John M; Park, Samuel et al. (2003) Extracellular glutamate decrease in accumbens following cued food delivery. Neuroreport 14:991-4
West, A R; Galloway, M P (1998) Nitric oxide and potassium chloride-facilitated striatal dopamine efflux in vivo: role of calcium-dependent release mechanisms. Neurochem Int 33:493-501
West, A R; Galloway, M P (1997) Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms. Neuropharmacology 36:1571-81
West, A R; Galloway, M P (1997) Inhibition of glutamate reuptake potentiates endogenous nitric oxide-facilitated dopamine efflux in the rat striatum: an in vivo microdialysis study. Neurosci Lett 230:21-4
Koch, S; Galloway, M P (1997) MDMA induced dopamine release in vivo: role of endogenous serotonin. J Neural Transm 104:135-46
West, A R; Galloway, M P (1996) Intrastriatal infusion of (+/-)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: an in vivo microdialysis study in chloral hydrate-anesthetized rats. J Neurochem 66:1971-80
Aretha, C W; Galloway, M P (1996) Dopamine autoreceptor reserve in vitro: possible role of dopamine D3 receptors. Eur J Pharmacol 305:119-22
West, A R; Galloway, M P (1996) Regulation of serotonin-facilitated dopamine release in vivo: the role of protein kinase A activating transduction mechanisms. Synapse 23:20-7
Galloway, M P; Suchowski, C S; Keegan, M J et al. (1993) Local infusion of the selective 5HT-1b agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse 15:90-2
Benloucif, S; Keegan, M J; Galloway, M P (1993) Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Ther 265:373-7

Showing the most recent 10 out of 18 publications